Michael Gemki
banner
michigemki.bsky.social
Michael Gemki
@michigemki.bsky.social
⚗️ | ⚽ | 🏌️‍♂️ - Organic Synthesis Focused – Driven by Application @fz-juelich.de | ↗️ Make Tetrahedron Great Again.. 😃 | 🇪🇺 😘
Reposted by Michael Gemki
Publication charges
December 5, 2025 at 2:17 PM
Reposted by Michael Gemki
The vast method development uses photochemistry as a guiding light through many steps in the synthesis of complex target molecules. General concepts with recent examples on the use of photochemistry in natural product synthesis are discussed. Thanks to Elina!
#ChemSky

pubs.acs.org/doi/10.1021/...
Harnessing Photochemistry in Natural Product Synthesis: From Strategy to Applications
Photochemistry and total synthesis are deeply rooted in the history of organic chemistry, each developing independently while also intersecting frequently. Indeed, mild reaction conditions, versatility of transformations, and complementary selectivities to thermal methods make photochemistry an especially powerful tool for the synthesis of complex target molecules. In this Review, we highlight recent examples of total syntheses (from 2020 to 2025) featuring photochemical reactions as pivotal steps. Although the application of photochemistry in total synthesis has been consistently reviewed throughout the past decades, we feel that the wider emergence of photocatalytic methods, together with the continued importance of certain direct irradiation approaches, warrants its own discussion. We hope that our analytical approach and strategic insights will help us to identify cases where photochemical reactions could prove useful, thereby further encouraging their use in total syntheses.
pubs.acs.org
November 11, 2025 at 2:38 PM
Reposted by Michael Gemki
May I recommend this series:
Published annually by Pfizer Merck Takeda and others
Review of synthetic methods to marketed drugs
Great look at the current state of pharma synthesis
Synthetic Approaches to the New Drugs Approved during 2023
This review is the next installment of an annual series that discusses the synthetic routes to access 28 small molecule drugs that were approved worldwide in 2023. A brief description of each drug’s m...
pubs.acs.org
November 13, 2025 at 12:58 AM
Reposted by Michael Gemki
November 3, 2025 at 11:58 PM
Reposted by Michael Gemki
At #ACSFall2025, 13 researchers working at pharmaceutical giants and small biotech firms revealed the structures of their drug candidates and shared each molecule’s journey from initial discovery campaign to the clinic. cen.acs.org/pharmaceutic... #chemsky 🧪
Structures of 13 drug candidates unveiled at DC meeting
First-time disclosures session at ACS Fall 2025 reveals diverse candidates for treating sickle cell disease, heart failure, cancer, and more
cen.acs.org
October 29, 2025 at 5:18 PM
Reposted by Michael Gemki
Commercial/lrg scale of API generally avoids glove-box type reactions - this annual review is chock full of “regular” reactions used for scale up
Synthetic Approaches to the New Drugs Approved during 2023
This review is the next installment of an annual series that discusses the synthetic routes to access 28 small molecule drugs that were approved worldwide in 2023. A brief description of each drug’s m...
pubs.acs.org
June 4, 2025 at 9:12 PM
Reposted by Michael Gemki
Diese Kürzungen im Hochschulbereich sind eine Katastrophe und viel zu wenig beachtet. Wir reden über die Wissenschafts-Missstände in den USA, aber schleichend wird auch hier Bildung und Wissenschaft kaputtgespart. #ichbinhanna ist nur ein Symptom von vielen.

www.fzs.de/wp-content/u...
www.fzs.de
April 11, 2025 at 5:43 AM
Reposted by Michael Gemki
Next up we’ll have a talk from @stephanhacker2.bsky.social about identifying electrophiles to target amino acids beyond cysteine, including the first probes to globally monitor tryptophans, histidines and arginines ✨

chemrxiv.org/engage/chemr...
Profiling the proteome-wide selectivity of diverse electrophiles
Targeted covalent inhibitors are powerful entities in drug discovery, but their application has so far mainly been limited to addressing cysteine residues. The development of cysteine-directed covalen...
chemrxiv.org
March 30, 2025 at 10:10 AM
Reposted by Michael Gemki
🧬💡 mRNA-Impfstoffe gegen COVID-19 rufen nicht nur klassische Immunantworten hervor, sondern prägen langfristig auch das angeborene #Immunsystem. 💉
Das zeigt ein Team um Jan Rybniker und @epistrucstab.bsky.social der #UniKöln und @uniklinikkoeln.bsky.social 🦠 👇
uni.koeln/EXDKG
#mrna #Impfung #covid
mRNA-Coronaimpfung trainiert das „Langzeitgedächtnis“ des Immunsystems
Forschende der Universität zu Köln zeigen, dass COVID-19-Impfstoffe auf der Grundlage von mRNA das angeborene Immunsystem langfristig prägen. Diese Mechanismen können bewirken, dass der menschliche Kö...
uni.koeln
March 26, 2025 at 1:36 PM
Reposted by Michael Gemki
#ChemSky cool new paper in #Orglett asap from Kyoto University using an activated pyridinium EDA complex to easily deoxygenate R-OH via radical process. Radical can be used for coupling as well. Seems a straightforward set up and useful
A Sterically Tuned 2-Fluoropyridinium Salt for the Catalyst-Free, Visible-Light-Mediated Deoxygenation of Alcohols via an Electron Donor–Acceptor Complex
We here report the use of a sterically tuned 2-fluoro-1-methylpyridinium salt for the catalyst-free, visible-light-mediated deoxygenative transformation of alcohols through alkoxypyridinium intermedia...
doi.org
March 9, 2025 at 12:42 AM
Reposted by Michael Gemki
It's finally out – actually out and in print! Many thanks to @jcornlab.bsky.social @matthiasmuhar.bsky.social @jakobfarnung.bsky.social and all the fantastic collaborators. What started as pure curiosity lead to an amazing find!

www.nature.com/articles/s41...
C-terminal amides mark proteins for degradation via SCF–FBXO31 - Nature
SCF–FBXO31 scans proteins for C-terminal amidation and marks them for subsequent proteasomal degradation.
www.nature.com
February 12, 2025 at 8:23 PM
Reposted by Michael Gemki
PhD position to apply with Alexander Haseloer at research center Jülich. Despite titled "Neurosciences", it's more separation chemistry, nuclear data and coordination chemistry.
🧪
February 7, 2025 at 1:12 PM
Reposted by Michael Gemki
If you work in drug discovery and you read one thing this weekend, make it this exceptional J Med Chem editorial. Hits on almost every blessed thing I’ve tweetorialized over the last several years.

Quantitation and Error Measurements in Dose–Response Curves
Quantitation and Error Measurements in Dose–Response Curves
pubs.acs.org
January 31, 2025 at 6:30 PM